Clinical Trial Update: Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sacituzumab govitecan plus zimberelimab for patients with non-small cell lung cancer confined to the chest who have been operated on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Fundación GECP | Conditions: Lung Diseases, Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: RECRUITING